Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03699852 |
Other study ID # |
Rosadélia |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
December 11, 2018 |
Est. completion date |
January 10, 2020 |
Study information
Verified date |
May 2021 |
Source |
University of Nove de Julho |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This is a clinical study with a controlled series of cases, whose objectives were: to
evaluate the effects of FBM, using LED, on the repair process of the skin graft donor area
treated with Membracel® and LED versus Membracel ®; to evaluate the evolution of the quality
of the aspects of the skin donor area, through the score obtained by the modified
Bates-Jensen Scale; the intensity of the pain reported by the participants; the size of the
wound area until the 7th postoperative (PO) period and the time for re-epithelialization of
the donor area. Data collection was performed at the Burn Unit of the General Hospital "Dr.
José Pangella", from Vila Penteado, São Paulo, Brazil. The sample consisted of 21
participants and 25 donor areas, 13 of which were from the control group, which received only
conventional treatment (Membracel®) and 12 from the experimental group: Membracel® and LED.
Data collection instruments were used: medical records of the participants, anamnesis and
physical examination, the scales: pain (Visual Analogic Scale - VAS) and Bates-Jensen to
accompany the re-epithelialization process and the measurement of donor skin areas in the
postoperative period. Quantitative variables were represented by the mean, standard deviation
and the median and interquartile range. The comparison of the distributions of these
variables between groups was performed using the Mann-Whitney test.
Description:
The use of FBM, showing beneficial effects on wounds, is well described in the literature.
The reported findings include anti-inflammatory action, better tissue organization,
acceleration of angiogenesis, stimulation of leukocyte chemotaxis and reduction of donor area
size in animals and humans. This is a clinical study with a controlled series of cases, whose
objectives were: to evaluate the effects of FBM, using LED, on the repair process of the skin
graft donor area treated with Membracel® and LED versus Membracel ®; to evaluate the
evolution of the quality of the aspects of the skin donor area, through the score obtained by
the modified Bates-Jensen Scale; the intensity of the pain reported by the participants; the
size of the wound area until the 7th postoperative (PO) period and the time for
re-epithelialization of the donor area. Data collection was performed at the Burn Unit of the
General Hospital "Dr. José Pangella", from Vila Penteado, São Paulo, Brazil, from December
2018 to January 2020. The sample consisted of 21 participants and 25 donor areas, 13 of which
were from the control group, which received only conventional treatment (Membracel®) and 12
from the experimental group: Membracel® and LED. Data collection instruments were used:
medical records of the participants, anamnesis and physical examination, the scales: pain
(Visual Analogic Scale - VAS) and Bates-Jensen to accompany the re-epithelialization process
and the measurement of donor skin areas in the postoperative period. Participants were
identified by Arabic numbers, according to the order of arrival at the Hospital. Quantitative
variables were represented by the mean, standard deviation and the median and interquartile
range. The comparison of the distributions of these variables between groups was performed
using the Mann-Whitney test.